Scarica l'app Stockscreener
49.14
0.61%
0.30
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Soleno Therapeutics Inc Borsa (SLNO) Ultime notizie
Soleno Therapeutics (NASDAQ:SLNO) Share Price Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat
Soleno Therapeutics Inc (NASDAQ:SLNO) Nasdaq today Biopharma Niche Growth - Kalkine Media
Precision Trading with Soleno Therapeutics Inc. (SLNO) Risk Zones - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Investors to Inquire about Securities Investigation - ACCESS Newswire
Is Soleno Therapeutics (NASDAQ:SLNO) Using Debt Sensibly? - 富途牛牛
Fed Meeting: What momentum indicators show for Soleno Therapeutics Inc. stock2025 Market WrapUp & Weekly Return Optimization Alerts - Улправда
Will Soleno Therapeutics Inc. stock see insider buyingQuarterly Portfolio Report & Accurate Entry/Exit Alerts - Улправда
Is Soleno Therapeutics Inc. stock affected by interest rate hikesIPO Watch & Short-Term Trading Opportunity Alerts - ulpravda.ru
Why Soleno Therapeutics Inc. stock could rally in 2025Dollar Strength & Weekly Top Stock Performers List - Улправда
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Soleno Therapeutics, Inc. (SLNO) And Encourages Investors to Reach Out - ACCESS Newswire
Can Soleno Therapeutics Inc. stock hit record highs again2025 Year in Review & Fast Gaining Stock Reports - DonanımHaber
How Soleno Therapeutics Inc. stock performs in weak economyPortfolio Risk Report & Low Drawdown Momentum Trade Ideas - Улправда
Rate Hike: What momentum indicators show for Soleno Therapeutics Inc. stockJuly 2025 Technicals & Community Verified Trade Signals - ulpravda.ru
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Soleno Therapeutics, Inc. (SLNO) And Encourages Stockholders to Reach Out - ACCESS Newswire
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeu - GuruFocus
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses - PR Newswire
Reassessing Soleno Therapeutics (SLNO) Valuation After Wolfe Research’s Confidence Boost and Improving Fundamentals - Sahm
Soleno Therapeutics (SLNO) Valuation Check After Wolfe Research’s Optimistic New Coverage and Stock Pop - Yahoo Finance
How Soleno Therapeutics' Audit Committee Leadership Transition At Soleno Therapeutics (SLNO) Has Changed Its Investment Story - Yahoo Finance
34,840 Shares in Soleno Therapeutics, Inc. $SLNO Purchased by Castleark Management LLC - MarketBeat
Soleno Therapeutics Gains Momentum Following Wolfe Research Favorable Rating - timothysykes.com
Soleno Therapeutics, Inc. $SLNO Shares Sold by Holocene Advisors LP - MarketBeat
Soleno Therapeutics Stock Poised for Growth as Wolfe Research Issues Positive Rating - StocksToTrade
Soleno Therapeutics Rises as Wolfe Research Gives Positive Outlook - timothysykes.com
Adage Capital Partners GP L.L.C. Decreases Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat
Will Vykat XR Approval and Board Shift Reshape Soleno Therapeutics' (SLNO) Investment Narrative? - Sahm
Valuation Update: Will Soleno Therapeutics Inc. stock recover faster than peersJuly 2025 Pullbacks & AI Powered Market Entry Ideas - moha.gov.vn
Soleno Therapeutics (SLNO) Reports Strong Q3 Earnings Despite VYKAT XR Safety Concerns - MSN
Technical Reactions to SLNO Trends in Macro Strategies - news.stocktradersdaily.com
Soleno Therapeutics (NASDAQ:SLNO) Shares Gap UpStill a Buy? - MarketBeat
Rhythm Pharma Strikes Chord As Early PWS Trial Results Show Promise - Benzinga
Is Soleno Therapeutics, Inc. (SLNO) The Cheap Healthcare Stock To Buy Heading Into 2026? - Insider Monkey
Gainers Report: What insider trading reveals about Soleno Therapeutics Inc stockOil Prices & High Return Trade Guides - moha.gov.vn
Diadema Partners LP Has $23.81 Million Stock Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat
Soleno Therapeutics, Inc. $SLNO Stake Reduced by Vivo Capital LLC - MarketBeat
Marshall Wace LLP Purchases 164,580 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat
Aug Movers: How buybacks impact Soleno Therapeutics Inc stock valueJuly 2025 Big Picture & Real-Time Buy Signal Notifications - moha.gov.vn
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Russell Investments Group Ltd. Acquires 82,932 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat
Rhumbline Advisers Acquires 22,607 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat
Soleno Therapeutics board member William Harris passes away By Investing.com - Investing.com Canada
Will Soleno Therapeutics Inc. stock deliver shareholder valueJuly 2025 Short Interest & Verified High Yield Trade Plans - Newser
Why Soleno Therapeutics Inc. (6XC) stock remains stableEarnings Summary Report & High Accuracy Buy Signal Tips - Newser
Is Soleno Therapeutics Inc. stock in correction or buying zoneEarnings Growth Summary & Technical Pattern Based Buy Signals - Newser
Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet? - Nasdaq
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact ... - Enidnews.com
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, - GlobeNewswire
Soleno Therapeutics board member William Harris passes away - Investing.com
Soleno Therapeutics Announces the Passing of Board Member William G. Harris - The Manila Times
Soleno Therapeutics, Inc. Announces Demise of William G. Harris, Member of Board of Directors and Audit Committee Changes - marketscreener.com
0.36%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):